This week, the federal government announced it would begin processing dozens of pending applications for the “steps necessary to improve access to cannabis research.”
Additionally, companies hoping to obtain U.S. Drug Enforcement Agency Registration for a federal bulk manufacturer licenses to cultivate cannabis for scientific research as well as for manufacturing FDA-approved pharmaceuticals, are seemingly one step closer, with an arsenal of caveats.
“I am pleased that DEA is moving forward with its review of applications for those who seek to grow cannabis legally to support research,” said Attorney General William P. Barr, in a statement released by the Department of Justice’s (DOJ) Office of Public Affairs. “The Department of Justice will continue to work with our colleagues at the Department of Health and Human Services and across the Administration to improve research opportunities wherever we can.”
According to NPR, the DEA’s decision comes after several years of delay for some applicants and a lawsuit filed against the agency by one cannabis researcher, Dr. Sue Sisley who heads the Scottsdale Research Institute in Arizona, which studies cannabis.
In response, “DEA is making progress in the program to register additional cannabis growers for federally authorized research, and will work with other relevant federal agencies to expedite the necessary next steps,” said DEA Acting Administrator Uttam Dhillon. “We support additional research into cannabis and its components, and we believe registering more growers will result in researchers having access to a wider variety for study.”
Read more at forbes.com